Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

Ursodiol for Cholestasis of Pregnancy: Does It Help?

Assigned clinical reviewerMatt Stahl· PharmDDraft · pending clinical reviewUpdated

What does the evidence say about ursodiol during pregnancy?

  1. SMFM Consult Series 53, endorsed by ACOG and indexed by PubMed, recommends ursodeoxycholic acid as first-line medication for maternal symptoms of intrahepatic cholestasis and recommends measuring bile acids and liver enzymes when the disorder is suspected. 1
  2. PITCHES randomized 605 pregnant participants with intrahepatic cholestasis to ursodeoxycholic acid or placebo. The primary perinatal composite occurred in 23 percent versus 27 percent, adjusted risk ratio 0.85 with a 95 percent confidence interval of 0.62 to 1.15, which was not statistically significant. 2
  3. A secondary PITCHES analysis found no baseline bile-acid or itch-severity subgroup with a clinically meaningful ursodiol response. A small itch-score difference in one subgroup was statistically significant but below the investigators' threshold for clinical importance. 3
  4. An individual-participant-data meta-analysis found no significant difference in stillbirth with ursodiol: 0.7 percent among exposed pregnancies and 0.6 percent among unexposed pregnancies, adjusted odds ratio 1.04 with a 95 percent confidence interval of 0.35 to 3.07. 4
  5. In the randomized-trial subset of that meta-analysis, ursodiol was associated with fewer total preterm births and a lower composite of stillbirth or preterm birth. Stillbirth alone remained too rare for a reliable conclusion, and subgroup interaction tests did not establish a unique bile-acid threshold response. 4

Is ursodiol safe in each trimester?

  • First trimester. Intrahepatic cholestasis is unusual this early, so new itching needs clinical and laboratory evaluation rather than self-started ursodiol. Confirmed disease requires specialist assessment for other liver causes and an individualized medication plan.
  • Second trimester. For confirmed cholestasis, ursodiol may be offered for maternal symptoms while serial bile acids and the broader pregnancy plan continue. A change in itching does not reliably show whether fetal risk has changed.
  • Third trimester. Bile-acid level and gestational age help guide delivery timing. Ursodiol does not replace surveillance or planned delivery, and current evidence does not establish that it lowers stillbirth risk.

Frequently asked questions

Does ursodiol relieve itching from cholestasis of pregnancy?

Guidelines recommend ursodiol first for maternal symptoms, but average itch improvement in the largest trial was modest. A secondary analysis did not find a baseline itch or bile-acid subgroup with a clearly clinically important response.

Is ursodiol considered safe for the baby during pregnancy?

PITCHES reported no serious adverse events considered related to ursodiol, and guidelines use it in pregnancy. That supports clinical use but does not prove fetal benefit or eliminate the risks associated with cholestasis itself.

Does ursodiol lower stillbirth risk in cholestasis?

Current studies do not establish a lower stillbirth risk. The individual-participant-data meta-analysis found no significant stillbirth difference, with a wide confidence interval because stillbirth was rare.

Can ursodiol reduce preterm birth?

The randomized-trial subset of a large meta-analysis found fewer total preterm births with ursodiol, but the evidence does not show that every patient receives that benefit. Bile-acid severity and delivery planning remain important.

How long is ursodiol taken during pregnancy?

In PITCHES, participants used the assigned medicine from enrollment until delivery. Real-world duration depends on a confirmed condition, response, bile-acid results, side effects, and the delivery plan, so the prescriber sets the start and stop dates.

What ursodiol dose was used in the PITCHES trial?

PITCHES started ursodeoxycholic acid at 500 mg twice daily and allowed adjustment from one to four 500 mg tablets daily. That trial protocol is not a self-dosing instruction; pregnancy prescribing should be individualized.

Does a lower itch score mean bile acids and fetal risk are lower?

No. Itch severity and bile-acid concentration are not interchangeable, and symptom change cannot replace blood testing. Continue the monitoring and delivery plan even if itching improves.

Does ursodiol replace early-delivery planning for cholestasis?

No. SMFM recommendations use bile-acid concentration to guide delivery timing and advise against preterm delivery before 37 weeks without laboratory confirmation. Ursodiol does not replace that risk-based plan.

Are ursodiol and ursodeoxycholic acid the same medicine?

Yes. Ursodiol is the United States name commonly used for ursodeoxycholic acid, often abbreviated UDCA in studies. Brand, tablet strength, and prescribed dose can still differ.

Related in the library

References

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.